Home / Health / Statins for Seniors: New Trial Offers Lifeline
Statins for Seniors: New Trial Offers Lifeline
30 Aug
Summary
- Statins cut major cardiovascular event risk by 30% in over-70s.
- Trial results could expand NHS statin prescriptions for the elderly.
- Statins did not significantly improve disability-free survival in the study.
A significant six-year trial has demonstrated that statins can decrease the risk of major cardiovascular events, including heart attacks and strokes, by 30% in individuals aged 70 and over. These findings, unveiled at the European Society of Cardiology Congress in Munich, suggest a potential shift in NHS prescribing practices for the elderly. Currently, only about 40% of Britons over 70 take statins, despite this age group facing a greater risk of fatal heart events.
The research aimed to determine if statins should be used preventatively in older adults before the onset of conditions like cardiovascular disease, diabetes, or dementia. While the trial showed a clear benefit in reducing cardiovascular risks, it also found no significant improvement in disability-free survival, defined as survival free from dementia and physical disability.
Concerns about statin side effects, such as muscle aches and fatigue, along with the risk of drug interactions due to 'polypharmacy' in older adults, have historically led to caution in prescribing them for prevention. However, the results from this large Australian trial provide robust evidence for the safety and efficacy of statins in older populations, addressing a critical gap in clinical trial data for this demographic.
